3Panhotra BR, Saxena AK, Al-Ghamdi AM, et al. Extendedspectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome [J].Saudi Med J,2004,25(12) :1871-1876.
4Chen KY,Hsueh PR,Liaw YS,et al. A 10-year experience with bacteriology of acute thoracic empyema:emphasis on Klebsiella pneumoniae in patients with diabetes mellitus[J]. Chest, 2000, 117 (6) :1685-1689.
5Paterson DL, Ko WC, von Gottberg A, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections[J]. Ann Intern Med, 2004,140 (1) : 26- 32.
6Hyle EP,Lipworth AD, Zaoatis TE, et al. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection[J].Arch Intern Med, 2005,165 (12) :1375-1380.
6Goossens H.MYSTIC program:summary of European data from 1997 to 2000.Diagn Microbiol Infect Dis,2001,41:183-189.
7Yu YS,Zhou WL,Chen YG,et al.Epidemiological and antibiotic resistant study on extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.Chin Med J,2002,115:1479-1482.
8Paterson DL,Mulazimoglu L,Casellas JM,et al.Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.Clin Infect Dis,2000,30:473-478.
9Yu WL,Jones RN,Hollis RJ,et al.Molecular epidemiology of extended-spectrum β-lactamase producing,fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan.J Clin Microbiol,2002,40:4666-4669.
10Bedenic B,Beader N,Zagar Z.Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended spectrum beta-lactamases.Clin Microbiol Infect,2001,7:626-635.
